Trending in Health
Today’s most discussed stories
FDA Approves Wegovy Pill, Transforming Weight Loss Treatment
The FDA has approved Wegovy in pill form, a groundbreaking development in obesity treatment. This marks the first daily oral weight-loss medication, enhancing accessibility for patients. Novo Nordisk's shares surged following this approval, positioning the company favorably in the competitive weight-loss market against rivals like Eli Lilly.
Be the Premium Story on Top Trending
Own the #1 slot on Top Trending. Massive visibility when attention is highest.
FDA Approves First Oral Weight Loss Pill Wegovy from Novo Nordisk
The FDA has approved Wegovy, the first oral formulation of a weight-loss medication developed by Novo Nordisk. Set to be available in the U.S. at a price of $149 per month starting next year, this approval represents a significant advancement in obesity management options for patients.
Why World Pulse Now
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system has analyzed 3,678 articles worldwide
~153 per hour
254 trending stories shaping headlines
From breaking news to viral moments
Monitoring 309 trusted sources
Major outlets & specialized publications
Latest update 2 days ago
Always fresh
Featured Products
View the complete directory of tools and products.